Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Limited HIV-2 reservoirs in central-memory CD4 T-cells associated to CXCR6 co-receptor expression in attenuated HIV-2 infection.

Samri A, Charpentier C, Diallo MS, Bertine M, Even S, Morin V, Oudin A, Parizot C, Collin G, Hosmalin A, Cheynier R, Thiébaut R, Matheron S, Collin F, Zoorob R, Brun-Vézinet F, Autran B; ANRS CO5 IMMUNOVIR-2 Study Group.

PLoS Pathog. 2019 May 16;15(5):e1007758. doi: 10.1371/journal.ppat.1007758. eCollection 2019 May.

2.

B7-H6-mediated downregulation of NKp30 in natural killer cells contributes to HIV-2 immune escape.

Lucar O, Sadjo Diallo M, Bayard C, Samri A, Tarantino N, Debré P, Thiébaut R, Brun-Vézinet F, Matheron S, Cheynier R, Vieillard V; ANRS CO5 IMMUNOVIR-2 Study group.

AIDS. 2019 Jan 27;33(1):23-32. doi: 10.1097/QAD.0000000000002061.

PMID:
30325780
3.

Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients.

Colin de Verdiere N, Durier C, Samri A, Meiffredy V, Launay O, Matheron S, Mercier-Delarue S, Even S, Aboulker JP, Molina JM, Autran B, Simon F; ANRS EP46 NOVAA Group.

AIDS. 2018 Oct 23;32(16):2291-2299. doi: 10.1097/QAD.0000000000001963.

PMID:
30096071
4.

What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM.

Bendenoun M, Samri A, Avettand-Fènoël V, Cardinaud S, Descours B, Carcelain G, Mazeron MC, Bergmann JF, Urrutia A, Moris A, Rouzioux C, Simon F, Andre P, Pocard M, Dray X, Mourez T, Vieillard V, Autran B, Barin F, Sellier P.

EBioMedicine. 2018 Jan;27:51-60. doi: 10.1016/j.ebiom.2017.12.003. Epub 2017 Dec 7.

5.

Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer.

Guihot A, Marcelin AG, Massiani MA, Samri A, Soulié C, Autran B, Spano JP.

Ann Oncol. 2018 Feb 1;29(2):517-518. doi: 10.1093/annonc/mdx696. No abstract available.

6.

Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status.

Lucar O, Su B, Potard V, Samri A, Autran B, Moog C, Debré P, Vieillard V.

EBioMedicine. 2017 Aug;22:122-132. doi: 10.1016/j.ebiom.2017.07.007. Epub 2017 Jul 11.

7.

HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection.

Rouers A, Klingler J, Su B, Samri A, Laumond G, Even S, Avettand-Fenoel V, Richetta C, Paul N, Boufassa F, Hocqueloux L, Mouquet H, Rouzioux C, Lambotte O, Autran B, Graff-Dubois S, Moog C, Moris A; ANRS CO21 Cohort.

EBioMedicine. 2017 Jul;21:158-169. doi: 10.1016/j.ebiom.2017.05.029. Epub 2017 May 31.

8.

Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation.

Yong MK, Cameron PU, Slavin M, Morrissey CO, Bergin K, Spencer A, Ritchie D, Cheng AC, Samri A, Carcelain G, Autran B, Lewin SR.

J Infect Dis. 2017 Jun 1;215(11):1684-1694. doi: 10.1093/infdis/jix192.

PMID:
28431019
9.

Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab.

Le Garff G, Samri A, Lambert-Niclot S, Even S, Lavolé A, Cadranel J, Spano JP, Autran B, Marcelin AG, Guihot A.

AIDS. 2017 Apr 24;31(7):1048-1051. doi: 10.1097/QAD.0000000000001429. No abstract available.

PMID:
28350581
10.

Polyfunctional HIV-specific T cells in Post-Treatment Controllers.

Samri A, Bacchus-Souffan C, Hocqueloux L, Avettand-Fenoel V, Descours B, Theodorou I, Larsen M, Saez-Cirion A, Rouzioux C, Autran B; ANRS VISCONTI study group.

AIDS. 2016 Sep 24;30(15):2299-302. doi: 10.1097/QAD.0000000000001195.

PMID:
27428742
11.

Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, randomized, multicentre trial (IMEA 040 DATA trial).

Slama L, Landman R, Assoumou L, Benalycherif A, Samri A, Joly V, Pialoux G, Valin N, Cabié A, Duvivier C, Lambert-Niclot S, Marcelin AG, Peytavin G, Costagliola D, Girard PM; IMEA 040 DATA Study Group.

J Antimicrob Chemother. 2016 Aug;71(8):2252-61. doi: 10.1093/jac/dkw103. Epub 2016 Apr 10.

PMID:
27068399
12.

HIV-Infected Spleens Present Altered Follicular Helper T Cell (Tfh) Subsets and Skewed B Cell Maturation.

Colineau L, Rouers A, Yamamoto T, Xu Y, Urrutia A, Pham HP, Cardinaud S, Samri A, Dorgham K, Coulon PG, Cheynier R, Hosmalin A, Oksenhendler E, Six A, Kelleher AD, Zaunders J, Koup RA, Autran B, Moris A, Graff-Dubois S.

PLoS One. 2015 Oct 26;10(10):e0140978. doi: 10.1371/journal.pone.0140978. eCollection 2015.

13.

Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission.

Chéret A, Bacchus-Souffan C, Avettand-Fenoël V, Mélard A, Nembot G, Blanc C, Samri A, Sáez-Cirión A, Hocqueloux L, Lascoux-Combe C, Allavena C, Goujard C, Valantin MA, Leplatois A, Meyer L, Rouzioux C, Autran B; OPTIPRIM ANRS-147 Study Group.

J Antimicrob Chemother. 2015 Jul;70(7):2108-20. doi: 10.1093/jac/dkv084. Epub 2015 Apr 21.

PMID:
25900157
14.

The HIV-1 antisense protein (ASP) induces CD8 T cell responses during chronic infection.

Bet A, Maze EA, Bansal A, Sterrett S, Gross A, Graff-Dubois S, Samri A, Guihot A, Katlama C, Theodorou I, Mesnard JM, Moris A, Goepfert PA, Cardinaud S.

Retrovirology. 2015 Feb 10;12:15. doi: 10.1186/s12977-015-0135-y.

15.

Increased carotid intima-media thickness is not associated with T-cell activation nor with cytomegalovirus in HIV-infected never-smoker patients.

Goulenok T, Boyd A, Larsen M, Fastenackels S, Boccara F, Meynard JL, Hadour N, Samri A, Desvarieux M, Autran B, Appay V, Girard PM, Sauce D; CHIC Study group.

AIDS. 2015 Jan 28;29(3):287-93. doi: 10.1097/QAD.0000000000000539.

PMID:
25686677
16.

Association of residual plasma viremia and intima-media thickness in antiretroviral-treated patients with controlled human immunodeficiency virus infection.

Boyd A, Meynard JL, Morand-Joubert L, Michon A, Boccara F, Bastard JP, Samri A, Haddour N, Mallat Z, Capeau J, Desvarieux M, Girard PM; Collaboration in HIV, Inflammation and Cardiovascular Disease Study.

PLoS One. 2014 Nov 21;9(11):e113876. doi: 10.1371/journal.pone.0113876. eCollection 2014.

17.

Characterization of pandemic influenza immune memory signature after vaccination or infection.

Bonduelle O, Carrat F, Luyt CE, Leport C, Mosnier A, Benhabiles N, Krivine A, Rozenberg F, Yahia N, Samri A, Rousset D, van der Werf S, Autran B, Combadiere B.

J Clin Invest. 2014 Jul;124(7):3129-36. doi: 10.1172/JCI74565. Epub 2014 Jun 9.

18.

Identical strength of the T cell responses against E2, nsP1 and capsid CHIKV proteins in recovered and chronic patients after the epidemics of 2005-2006 in La Reunion Island.

Hoarau JJ, Gay F, Pellé O, Samri A, Jaffar-Bandjee MC, Gasque P, Autran B.

PLoS One. 2013 Dec 23;8(12):e84695. doi: 10.1371/journal.pone.0084695. eCollection 2013.

19.

Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccination.

Bonduelle O, Yahia N, Siberil S, Benhabiles N, Carrat F, Krivine A, Rozenberg F, Dimitrov J, Kaveri SV, Curjol A, Tindel M, Louet M, Desert F, Launay O, Loulergue P, Badre G, Katlama C, Bricaire F, Samri A, Rousset D, van der Werf S, Jauréguiberry S, Combadiere B.

J Immunol. 2013 Jul 15;191(2):623-31. doi: 10.4049/jimmunol.1203483. Epub 2013 Jun 17.

20.

MHC-driven HIV-1 control on the long run is not systematically determined at early times post-HIV-1 infection.

Antoni G, Guergnon J, Meaudre C, Samri A, Boufassa F, Goujard C, Lambotte O, Autran B, Rouzioux C, Costagliola D, Meyer L, Theodorou I.

AIDS. 2013 Jul 17;27(11):1707-16. doi: 10.1097/QAD.0b013e328360a4bd.

PMID:
23462218
21.

Direct quantification of cell-associated HIV DNA in isolated rectal and blood memory CD4 T cells revealed their similar and low infection levels in long-term treated HIV-infected patients.

Descours B, Lambert-Niclot S, Mory B, Samri A, Charlotte F, Peytavin G, Tubiana R, Papagno L, Bacchus C, Lecardonnel F, Katlama C, Autran B, Marcelin AG, Valantin MA, Carcelain G; DECAMUNE and ORVACS Study Groups.

J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):255-9. doi: 10.1097/QAI.0b013e318282537f.

PMID:
23274932
22.

Lack of benefit of 3-month intensification with enfuvirtide plus optimized background regimen (OBR) versus OBR alone in patients with multiple therapeutic failures: the INNOVE study.

Morand-Joubert L, Ghosn J, Delaugerre C, Giffo B, Solas C, Samri A, Pinta A, Triglia A, Raffi F; Innove Study Group.

J Med Virol. 2012 Nov;84(11):1710-8. doi: 10.1002/jmv.23388.

PMID:
22997073
23.

Human immunodeficiency virus type-1 (HIV-1) continues to evolve in presence of broadly neutralizing antibodies more than ten years after infection.

Chaillon A, Braibant M, Hué S, Bencharif S, Enard D, Moreau A, Samri A, Agut H, Barin F.

PLoS One. 2012;7(8):e44163. doi: 10.1371/journal.pone.0044163. Epub 2012 Aug 30.

24.

Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells.

Descours B, Avettand-Fenoel V, Blanc C, Samri A, Mélard A, Supervie V, Theodorou I, Carcelain G, Rouzioux C, Autran B; ALT ANRS CO15 Study Group.

Clin Infect Dis. 2012 May;54(10):1495-503. doi: 10.1093/cid/cis188. Epub 2012 Mar 22.

PMID:
22441653
25.

Lack of TGF-β production by hepatitis C virus-specific T cells during HCV acute phase is associated with HCV clearance in HIV coinfection.

Harfouch S, Guiguet M, Valantin MA, Samri A, Ouazene Z, Slama L, Dominguez S, Simon A, Theodorou I, Thibault V, Autran B; ANRS HC EP21 study group.

J Hepatol. 2012 Jun;56(6):1259-68. doi: 10.1016/j.jhep.2012.01.021. Epub 2012 Feb 9.

PMID:
22326469
26.

Maraviroc does not affect humoral response to the pandemic influenza A-H1N1v 2009 adjuvanted vaccine in HIV-1-infected patients.

Canestri A, Krivine A, Assoumou L, Le Corre M, Rozenberg F, Marcelin AG, Schneider L, Samri A, Carcelain G, Autran B, Katlama C, Guihot A.

AIDS. 2010 Nov 27;24(18):2887-9. doi: 10.1097/QAD.0b013e3283402bc1.

PMID:
20962616
27.

Distinct differentiation profiles of HIV-Gag and Nef-specific central memory CD8+ T cells associated with HLA-B57/5801 and virus control.

Xie J, Lu W, Samri A, Costagliola D, Schnuriger A, da Silva BC, Blanc C, Larsen M, Theodorou I, Rouzioux C, Autran B; ALT-ANRS-CO15 study group.

AIDS. 2010 Sep 24;24(15):2323-9. doi: 10.1097/QAD.0b013e32833e5009.

PMID:
20802296
28.

Disease progression due to dual infection in an HLA-B57-positive asymptomatic long-term nonprogressor infected with a nef-defective HIV-1 strain.

Braibant M, Xie J, Samri A, Agut H, Autran B, Barin F.

Virology. 2010 Sep 15;405(1):81-92. doi: 10.1016/j.virol.2010.05.026. Epub 2010 Jun 19.

29.

Routinely-feasible multiple biomarkers score to predict prognosis after revascularized STEMI.

Roubille F, Samri A, Cornillet L, Sportouch-Dukhan C, Davy JM, Raczka F, Gervasoni R, Pasquie JL, Cung TT, Piot C, Macia JC, Cransac F, Leclercq F.

Eur J Intern Med. 2010 Apr;21(2):131-6. doi: 10.1016/j.ejim.2009.11.011. Epub 2010 Jan 6.

PMID:
20206886
30.

Specific phenotypic and functional features of natural killer cells from HIV-infected long-term nonprogressors and HIV controllers.

Vieillard V, Fausther-Bovendo H, Samri A, Debré P; French Asymptomatiques à Long Terme (ALT) ANRS-CO15 Study Group.

J Acquir Immune Defic Syndr. 2010 Apr;53(5):564-73. doi: 10.1097/QAI.0b013e3181d0c5b4.

PMID:
20147841
31.

Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy.

Guihot A, Tubiana R, Breton G, Marcelin AG, Samri A, Assoumou L, Goncalves E, Bricaire F, Costagliola D, Calvez V, Rouzioux C, Autran B, Katlama C, Carcelain G; ALT-ANRS CO-15 study group; DECAMUNE study group.

AIDS. 2010 Feb 20;24(4):614-7. doi: 10.1097/QAD.0b013e32833556f3.

PMID:
19952710
32.

Preservation of immune function and anti-hepatitis C virus (HCV) immune responses after liver transplantation in HIV-HCV coinfected patients (ANRS-HC08 "THEVIC" trial).

Samri A, Roque-Afonso AM, Beran O, Tateo M, Teicher E, Feray C, Sebagh M, Guettier C, Dussaix E, Vittecoq D, Samuel D, Autran B, Duclos-Vallée JC.

J Hepatol. 2009 Dec;51(6):1000-9. doi: 10.1016/j.jhep.2009.06.031. Epub 2009 Sep 12.

PMID:
19833404
33.

Effect of lentivirus encoding HIV-1 Nef-U3 shRNA on the function of HIV-specific memory CD4(+) T cells in patients with chronic HIV-1 infection.

Yamamoto T, Samri A, Marcelin AG, Mitsuki YY, Vincent C, Autran B, Tsunetsugu-Yokota Y.

AIDS. 2009 Nov 13;23(17):2265-75. doi: 10.1097/QAD.0b013e328332817c.

PMID:
19786846
34.

Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells.

Bourgarit A, Carcelain G, Samri A, Parizot C, Lafaurie M, Abgrall S, Delcey V, Vicaut E, Sereni D, Autran B; PARADOX Study Group.

J Immunol. 2009 Sep 15;183(6):3915-23. doi: 10.4049/jimmunol.0804020.

35.

Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus.

Schnuriger A, Dominguez S, Guiguet M, Harfouch S, Samri A, Ouazene Z, Slama L, Simon A, Valantin MA, Thibault V, Autran B; ANRS HC EP21 study group.

AIDS. 2009 Oct 23;23(16):2079-89. doi: 10.1097/QAD.0b013e328330ed24.

PMID:
19710595
36.

Restoration of anti-tetanus toxoid responses in patients initiating highly active antiretroviral therapy with or without a boost immunization: an INITIO substudy.

Burton CT, Goodall RL, Samri A, Autran B, Kelleher AD, Poli G, Pantaleo G, Gotch FM, Imami N; INITIO Trial International Co-ordinating Committee.

Clin Exp Immunol. 2008 May;152(2):252-7. doi: 10.1111/j.1365-2249.2008.03611.x.

37.

Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover.

Almeida JR, Price DA, Papagno L, Arkoub ZA, Sauce D, Bornstein E, Asher TE, Samri A, Schnuriger A, Theodorou I, Costagliola D, Rouzioux C, Agut H, Marcelin AG, Douek D, Autran B, Appay V.

J Exp Med. 2007 Oct 1;204(10):2473-85. Epub 2007 Sep 24.

38.

Three-year immune reconstitution in PI-sparing and PI-containing antiretroviral regimens in advanced HIV-1 disease.

Samri A, Goodall R, Burton C, Imami N, Pantaleo G, Kelleher A, Poli G, Gotch F, Autran B.

Antivir Ther. 2007;12(4):553-8.

PMID:
17668564
39.

Trapping and apoptosis of novel subsets of memory T lymphocytes expressing CCR6 in the spleen of HIV-infected patients.

Lécureuil C, Combadière B, Mazoyer E, Bonduelle O, Samri A, Autran B, Debré P, Combadière C.

Blood. 2007 May 1;109(9):3649-57. Epub 2006 Dec 29.

PMID:
17197436
40.

Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assay.

Samri A, Durier C, Urrutia A, Sanchez I, Gahery-Segard H, Imbart S, Sinet M, Tartour E, Aboulker JP, Autran B, Venet A; ANRS ELISpot Standardization Group.

Clin Vaccine Immunol. 2006 Jun;13(6):684-97.

41.

Polymorphism in the proximal promoter region of the perforin gene and its impact on the course of HIV infection.

McIlroy D, Meyer L, Dudoit Y, Samri A, Delfraissy JF, Autran B, Debré P, Theodorou I.

Int J Immunogenet. 2006 Apr;33(2):73-9.

PMID:
16611250
42.

First Dominique Dormont International Conference on "Host-pathogen interactions in chronic infections - viral and host determinants of HCV, HCMV, and HIV infections".

Menu E, Müller-Trutwin MC, Pancino G, Saez-Cirion A, Bain C, Inchauspé G, Gras GS, Mabondzo AM, Samri A, Boutboul F, Le Grand R.

Retrovirology. 2005 Apr 6;2:24.

43.

Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication.

Alatrakchi N, Duvivier C, Costagliola D, Samri A, Marcelin AG, Kamkamidze G, Astriti M, Agher R, Calvez V, Autran B, Katlama C.

AIDS. 2005 Jan 3;19(1):25-33.

PMID:
15627030
44.

Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans.

Combadiere B, Boissonnas A, Carcelain G, Lefranc E, Samri A, Bricaire F, Debre P, Autran B.

J Exp Med. 2004 Jun 7;199(11):1585-93.

45.

A triple-mutated allele of granzyme B incapable of inducing apoptosis.

McIlroy D, Cartron PF, Tuffery P, Dudoit Y, Samri A, Autran B, Vallette FM, Debré P, Theodorou I.

Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2562-7. Epub 2003 Feb 19.

46.

A systematic comparison of methods to measure HIV-1 specific CD8 T cells.

Sun Y, Iglesias E, Samri A, Kamkamidze G, Decoville T, Carcelain G, Autran B.

J Immunol Methods. 2003 Jan 15;272(1-2):23-34.

PMID:
12505709
47.

A patient with HIV-1 superinfection.

Jost S, Bernard MC, Kaiser L, Yerly S, Hirschel B, Samri A, Autran B, Goh LE, Perrin L.

N Engl J Med. 2002 Sep 5;347(10):731-6. No abstract available.

48.

Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors.

McIlroy D, Troadec C, Grassi F, Samri A, Barrou B, Autran B, Debré P, Feuillard J, Hosmalin A.

Blood. 2001 Jun 1;97(11):3470-7.

PMID:
11369639
49.

HIV-specific effector cytotoxic T lymphocytes and HIV-producing cells colocalize in white pulps and germinal centers from infected patients.

Hosmalin A, Samri A, Dumaurier MJ, Dudoit Y, Oksenhendler E, Karmochkine M, Autran B, Wain-Hobson S, Cheynier R.

Blood. 2001 May 1;97(9):2695-701.

PMID:
11313260
50.

Supplemental Content

Support Center